| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Factors | RR | 95% CI | P | RR | 95% CI | P |
Lymphnode metastasis (negative/positive) | 2.91 | 1.86 to 5.03 | <0.0001 | 2.67 | 1.53 to 4.96 | <0.001 |
Hormone receptor (positive/negative) | 2.37 | 1.61 to 3.59 | <0.0001 | 2.65 | 1.62 to 4.43 | 0.0001 |
VEGFR-1 mRNA expression (negative/positive) | 1.86 | 1.19 to 2.79 | <0.01 | 2.00 | 1.19 to 3.25 | <0.01 |
CEA (<5.0 ng/ml/ >5.1 ng/ml) | 2.23 | 1.20 to 3.65 | <0.05 | 1.69 | 0.87 to 2.95 | 0.11 |
Tumor size (small/large) | 2.14 | 1.26 to 4.39 | <0.01 | 1.63 | 0.85 to 4.13 | 0.16 |
Nuclear grade (I and II/III) | 1.62 | 1.11 to 2.39 | <0.05 | 1.25 | 0.82 to 1.89 | 0.29 |
Lymphatic involvement (negative/positive) | 1.51 | 1.03 to 2.26 | <0.05 | 0.99 | 0.62 to 1.61 | 0.96 |
Vascular involvement (negative/positive) | 1.85 | 1.00 to 3.01 | 0.05 | - | - | - |
HER-2/NEU (negative/positive) | 1.48 | 0.96 to 2.26 | 0.08 | - | - | - |